Polpharma B2B Announces New Vice-President
Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer...
Polpharma B2B is a significant European active pharmaceutical ingredient (API) producer with current good manufacturing practice (cGMP) compliant and US Food and Drug Administration (FDA) approved manufacturing site.
The company's products are available on six continents in more than 60 countries. It is a well-known supplier of high-quality products and a trustworthy business partner of leading pharmaceutical companies worldwide.
Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer...
This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. Products...
Polpharma B2B's team of experts will be pleased to meet you at the CPhI Worldwide...
Polpharma B2B has announced it will be attending CPhI Worldwide 2018 in Madrid. The event...